All Pharma News
price-trendAsk Us
FDA approves AstraZeneca`s Airsupra rescue inhaler, but only for adults

FDA approves AstraZeneca`s Airsupra rescue inhaler, but only for adults
Eric Sagonowsky FIERCE PHARMA
12 Jan 2023
Share Share
US FDA accepts NDA filed by Avillion for AstraZeneca`s PT027 ion asthma

US FDA accepts NDA filed by Avillion for AstraZeneca`s PT027 ion asthma
PRNEWSWIRE
31 May 2022
Share Share
PT027, significantly Reduced the Risk of a Severe Exacerbation by 27% in Asthma

PT027, significantly Reduced the Risk of a Severe Exacerbation by 27% in Asthma
BUSINESSWIRE
15 May 2022
Share Share
Avillion/Merck psoriasis nanobody hits the mark in phase 2

Avillion/Merck psoriasis nanobody hits the mark in phase 2
Phil Taylor PHARMAPHORUM
27 Apr 2021
Share Share
Avillion`s positive Phase 2 trial of tri-specific Nanobody® sonelokimab (M1095)

Avillion`s positive Phase 2 trial of tri-specific Nanobody® sonelokimab (M1095)
PRNEWSWIRE
22 Apr 2021
Share Share
Positive results from Avillion`s Phase 2 trial of sonelokinab M1095

Positive results from Avillion`s Phase 2 trial of sonelokinab M1095
PRNEWSWIRE
29 Oct 2020
Share Share
Positive results from Avillion`s Phase 2 trial of sonelokinab (M1095)

Positive results from Avillion`s Phase 2 trial of sonelokinab (M1095)
PRNEWSWIRE
29 Oct 2020
Share Share
Abingworth lines up $315M to bet on a new generation of transatlantic biotechs

Abingworth lines up $315M to bet on a new generation of transatlantic biotechs
John Carroll ENDPTS
09 Jul 2018
Share Share